Sensitive content

This media may contain sensitive content.

Загрузка видео...

Не удалось загрузить видео

На главную

Video-endoscopic inguinal lymphadenectomy (VEIL) using the fascia first technique. Minimally invasive treatment, shorter hospital stay, fewer skin complications, shorter drainage time, less morbidity for patients with penile neoplasia; #veil #urosome

albertotm82's profile picture

Carlos Alberto Toledo Martínez

1,479 subscribers

20,875 просмотров • 2 месяцев назад •via X (Twitter)

NSFW#veil#urosome
LIVE

Anya Rossi• Live Now

Private livecam show

Комментарии: 0

Нет доступных комментариев

Здесь появятся комментарии из оригинального поста

Похожие видео

In patients with early septic shock, the ANDROMEDA‑SHOCK‑2 randomized clinical trial evaluated a personalized hemodynamic resuscitation protocol targeting normalization of capillary refill time. Compared with usual care, this strategy was superior for a hierarchical composite outcome of mortality, duration of vital support, and length of hospital stay at 28 days, with the overall benefit primarily attributable to a shorter duration of organ support. 🧵
2:55

In patients with early septic shock, the ANDROMEDA‑SHOCK‑2 randomized clinical trial evaluated a personalized hemodynamic resuscitation protocol targeting normalization of capillary refill time. Compared with usual care, this strategy was superior for a hierarchical composite outcome of mortality, duration of vital support, and length of hospital stay at 28 days, with the overall benefit primarily attributable to a shorter duration of organ support. 🧵

JAMA

13,414 просмотров • 5 месяцев назад

⭐️Had the pleasure of performing the first case at Geisinger GMC using the Hybridflex knife by ERBE 🗡️—also my first time using this tool. Achieved en bloc removal of a LNPCP (rectum). ✅Pros: faster procedure with fewer instrument exchanges, controlled dissection with the shorter knife length, excellent stability, and held up well even in retroflex. ❌Cons: still needed a dedicated injection for initial SM lift (only saline via knife), and limited pre-coagulation on vessels due to smaller shaft size. ASGE GI Endoscopy Geisinger GI #ERBEusa #MedTwitter #ESD
17:06

⭐️Had the pleasure of performing the first case at Geisinger GMC using the Hybridflex knife by ERBE 🗡️—also my first time using this tool. Achieved en bloc removal of a LNPCP (rectum). ✅Pros: faster procedure with fewer instrument exchanges, controlled dissection with the shorter knife length, excellent stability, and held up well even in retroflex. ❌Cons: still needed a dedicated injection for initial SM lift (only saline via knife), and limited pre-coagulation on vessels due to smaller shaft size. ASGE GI Endoscopy Geisinger GI #ERBEusa #MedTwitter #ESD

Danial H Shaikh, MD

11,820 просмотров • 1 год назад

*Video and images shown with full, written informed consent from the patient. Our first ESD of 2024, performed last week, using our saline-immersion technique (SITE)-facilitated, tri-tunnel variation of the pocket-creation method (PCM). The lesion was a 12 x 9cm laterally spreading tumour involving the ileocaecal valve, caecum and ascending colon*. Dissection speed: 28.3 mm^2/min. SITE, which we first described in 2016, enhances patient comfort (avoiding the need for deep sedation), obviates the need for any traction (through buoyancy), enhances optical clarity (through elimination of dissection-related smoke, fat micelles, debris and through intrinsic magnification), and enhances visualisation of vessels and bleeding points. The use of saline (not water) is critical for conductivity. High-effect, forced coagulation enables very effective knife-alone management of vessels and any bleeding, and this, coupled with the use of self-assembling protein matrix gel (Purastat), obviates the need for the use of coagulation forceps. All these factors contribute to increased efficiency, effectiveness and patient comfort. Histopathology of the specimen confirmed complete (R0) resection and showed that the lesion consisted of a low grade dysplastic lesion without any evidence of invasive malignancy, confirming cure. ESD is an endoscopic microsurgical technique which affords an en bloc, organ-preserving, minimally invasive cure for such lesions, which unlike piecemeal resection, offers R0 with virtually no risk of recurrence; this latter point eliminates the need for tight surveillance and related patient inconvenience/risk, also reducing cost and environmental impact. Onwards and upwards for the betterment of minimally invasive care for all our patients!
2:29

*Video and images shown with full, written informed consent from the patient. Our first ESD of 2024, performed last week, using our saline-immersion technique (SITE)-facilitated, tri-tunnel variation of the pocket-creation method (PCM). The lesion was a 12 x 9cm laterally spreading tumour involving the ileocaecal valve, caecum and ascending colon*. Dissection speed: 28.3 mm^2/min. SITE, which we first described in 2016, enhances patient comfort (avoiding the need for deep sedation), obviates the need for any traction (through buoyancy), enhances optical clarity (through elimination of dissection-related smoke, fat micelles, debris and through intrinsic magnification), and enhances visualisation of vessels and bleeding points. The use of saline (not water) is critical for conductivity. High-effect, forced coagulation enables very effective knife-alone management of vessels and any bleeding, and this, coupled with the use of self-assembling protein matrix gel (Purastat), obviates the need for the use of coagulation forceps. All these factors contribute to increased efficiency, effectiveness and patient comfort. Histopathology of the specimen confirmed complete (R0) resection and showed that the lesion consisted of a low grade dysplastic lesion without any evidence of invasive malignancy, confirming cure. ESD is an endoscopic microsurgical technique which affords an en bloc, organ-preserving, minimally invasive cure for such lesions, which unlike piecemeal resection, offers R0 with virtually no risk of recurrence; this latter point eliminates the need for tight surveillance and related patient inconvenience/risk, also reducing cost and environmental impact. Onwards and upwards for the betterment of minimally invasive care for all our patients!

Edward J. Despott

20,382 просмотров • 2 лет назад

I’ve just announced our nine Government Targets to be delivered by 2030. 1. Shorter stays in emergency departments: 95 per cent of patients to be admitted, discharged, or transferred from an emergency department within six hours. 2. Shorter wait times for (elective) treatment: 95 per cent of people wait less than four months for elective treatment. 3. Reduced child and youth offending: 15 per cent reduction in the total number of children and young people with serious and persistent offending behaviour. 4. Reduced violent crime: 20,000 fewer people who are victims of an assault, robbery, or sexual assault. 5. Fewer people on the Jobseeker Support Benefit: 50,000 fewer people on Jobseeker Support Benefit. 6. Increased student attendance: 80 per cent of students are present for more than 90 per cent of the term. 7. More students at expected curriculum levels: 80 per cent of Year 8 students at or above the expected curriculum level for their age in reading, writing and maths by December 2030. 8. Fewer people in emergency housing: 75 per cent reduction of households in emergency housing. 9. Reduced net greenhouse gas emissions: On track to meet New Zealand’s 2050 net zero climate change targets, with total net emissions of no more than 290 megatonnes from 2022 to 2025 and 305 megatonnes from 2026 to 2030.
0:35

I’ve just announced our nine Government Targets to be delivered by 2030. 1. Shorter stays in emergency departments: 95 per cent of patients to be admitted, discharged, or transferred from an emergency department within six hours. 2. Shorter wait times for (elective) treatment: 95 per cent of people wait less than four months for elective treatment. 3. Reduced child and youth offending: 15 per cent reduction in the total number of children and young people with serious and persistent offending behaviour. 4. Reduced violent crime: 20,000 fewer people who are victims of an assault, robbery, or sexual assault. 5. Fewer people on the Jobseeker Support Benefit: 50,000 fewer people on Jobseeker Support Benefit. 6. Increased student attendance: 80 per cent of students are present for more than 90 per cent of the term. 7. More students at expected curriculum levels: 80 per cent of Year 8 students at or above the expected curriculum level for their age in reading, writing and maths by December 2030. 8. Fewer people in emergency housing: 75 per cent reduction of households in emergency housing. 9. Reduced net greenhouse gas emissions: On track to meet New Zealand’s 2050 net zero climate change targets, with total net emissions of no more than 290 megatonnes from 2022 to 2025 and 305 megatonnes from 2026 to 2030.

Christopher Luxon

43,352 просмотров • 2 лет назад

🔍 Ultrasound-Guided Lumbar Puncture – an essential POCUS technique for improving procedural success in CSF sampling, especially in ↑BMI or anatomically challenging patients with spinal deformities or prior surgeries, minimizing traumatic taps, needle redirects, and complications to enhance diagnostic accuracy and patient safety in emergency, neurology, and critical care environments. Best annotated and explained video I’ve seen 🤩 ⚡ Employ pre-procedural static marking to locate optimal L3-L4/L4-L5 interspace, boosting first-pass success rates to over 90% in difficult cases and reducing overall attempts. 🩺 📏 paramedian sagittal views for hyperechoic spinous processes (crescent-shaped with shadowing) and transverse views for midline identification, ensuring precise needle trajectory and depth estimation. 📐 🚨 Switch to curvilinear probes in obese patients for better penetration; this halves failure rates compared to landmark-based methods, particularly when BMI exceeds 30. 📈 🔍 Incorporate real-time guidance to avoid bone contacts and minimize traumatic LPs (e.g., RBC counts <400/mm³), with meta-analyses showing fewer complications like post-dural puncture headaches. ⚠️ 🤝 Integrate ultrasound with clinical assessment (e.g., palpation, patient positioning in sitting/lateral recumbent) for holistic management, supported by randomized trials in adult and pediatric populations across ED and ICU settings. 👥
1:14

🔍 Ultrasound-Guided Lumbar Puncture – an essential POCUS technique for improving procedural success in CSF sampling, especially in ↑BMI or anatomically challenging patients with spinal deformities or prior surgeries, minimizing traumatic taps, needle redirects, and complications to enhance diagnostic accuracy and patient safety in emergency, neurology, and critical care environments. Best annotated and explained video I’ve seen 🤩 ⚡ Employ pre-procedural static marking to locate optimal L3-L4/L4-L5 interspace, boosting first-pass success rates to over 90% in difficult cases and reducing overall attempts. 🩺 📏 paramedian sagittal views for hyperechoic spinous processes (crescent-shaped with shadowing) and transverse views for midline identification, ensuring precise needle trajectory and depth estimation. 📐 🚨 Switch to curvilinear probes in obese patients for better penetration; this halves failure rates compared to landmark-based methods, particularly when BMI exceeds 30. 📈 🔍 Incorporate real-time guidance to avoid bone contacts and minimize traumatic LPs (e.g., RBC counts <400/mm³), with meta-analyses showing fewer complications like post-dural puncture headaches. ⚠️ 🤝 Integrate ultrasound with clinical assessment (e.g., palpation, patient positioning in sitting/lateral recumbent) for holistic management, supported by randomized trials in adult and pediatric populations across ED and ICU settings. 👥

POCUSmedicine

20,141 просмотров • 11 месяцев назад

with consistent buccal massage treatment, you unlock — decreased inflammation via stimulated lymph flow — improved facial symmetry through muscle relaxation — reduced TMJ dysfunction and jaw tension — increased ATP production and cellular detoxification — smoother fascia = fewer wrinkles and sagging — enhanced collagen synthesis from boosted circulation — normalized cortisol via parasympathetic activation — and long-term reeducation of facial muscle memory the buccal region (aka: the cheeks, lower face, and inside of your mouth) holds major lymphatic vessels, fascia, and muscle tension hotspots, especially the masseter and buccinator. these are two of the most overused muscles in the body. you clench them in your sleep. when you scroll. when you’re anxious. when you speak. and when they’re tight, they restrict blood flow, lymph flow, and literally pull your face downward. buccal facial massage — externally, it manually stimulates lymphatic drainage pathways along the jaw, cheek, and neck, reducing stagnant fluid, increasing microcirculation, and oxygenating the skin. — intraorally, fingers go inside the mouth to reach the inner surface of the buccinator and deep fascia. this releases chronic tension, improves neuromuscular function, and restores balance to the facial structure. translation? your face becomes tighter, lifted, sculpted—not because it’s frozen, but because it’s healthy. — sharper jawline — de-puffed under eyes — higher cheekbones — smoother nasolabial folds — brighter skin tone — actual nerve relaxation — and for some: less grinding, better sleep, even improved digestion (via vagus nerve stimulation) so if your face feels heavy, puffy, asymmetrical, or tired—it’s not “just genetics.” it’s stagnation. and lymphatic buccal massage is the antidote. get the tension out. let the lymph drain. and watch your real face reappear
0:24

with consistent buccal massage treatment, you unlock — decreased inflammation via stimulated lymph flow — improved facial symmetry through muscle relaxation — reduced TMJ dysfunction and jaw tension — increased ATP production and cellular detoxification — smoother fascia = fewer wrinkles and sagging — enhanced collagen synthesis from boosted circulation — normalized cortisol via parasympathetic activation — and long-term reeducation of facial muscle memory the buccal region (aka: the cheeks, lower face, and inside of your mouth) holds major lymphatic vessels, fascia, and muscle tension hotspots, especially the masseter and buccinator. these are two of the most overused muscles in the body. you clench them in your sleep. when you scroll. when you’re anxious. when you speak. and when they’re tight, they restrict blood flow, lymph flow, and literally pull your face downward. buccal facial massage — externally, it manually stimulates lymphatic drainage pathways along the jaw, cheek, and neck, reducing stagnant fluid, increasing microcirculation, and oxygenating the skin. — intraorally, fingers go inside the mouth to reach the inner surface of the buccinator and deep fascia. this releases chronic tension, improves neuromuscular function, and restores balance to the facial structure. translation? your face becomes tighter, lifted, sculpted—not because it’s frozen, but because it’s healthy. — sharper jawline — de-puffed under eyes — higher cheekbones — smoother nasolabial folds — brighter skin tone — actual nerve relaxation — and for some: less grinding, better sleep, even improved digestion (via vagus nerve stimulation) so if your face feels heavy, puffy, asymmetrical, or tired—it’s not “just genetics.” it’s stagnation. and lymphatic buccal massage is the antidote. get the tension out. let the lymph drain. and watch your real face reappear

raw milky

339,802 просмотров • 1 год назад

A full-time lifestyle influencer shares why she feels this path is no longer for her. Really great POV “I’m tired of making everything about myself. My job requires me to look at myself, talk about myself, post myself, and reply to comments about myself. It is way too much of a self-obsessive job” “On TikTok, you have to talk in short sentences. I’ve learned to not elaborate on my idea — which for years of my academic life, I was taught to elaborate on points. TikTok has kind of brainwashed me into just giving blurbs with zero explanation because the less you explain, the shorter the video, and the more comments you’ll get. I’ve gotten in the habit of giving less information” “I went on vacation and it was the first time in three years I was able to exist without that little voice in my head telling me you should be taking a photo right now, you should make a video about this, you should make a vlog, you should do a GRWM, you should post an update. It was liberating” “Usually my time is divided between me existing and then me posting about my existence. On this trip, I lived”
3:47

A full-time lifestyle influencer shares why she feels this path is no longer for her. Really great POV “I’m tired of making everything about myself. My job requires me to look at myself, talk about myself, post myself, and reply to comments about myself. It is way too much of a self-obsessive job” “On TikTok, you have to talk in short sentences. I’ve learned to not elaborate on my idea — which for years of my academic life, I was taught to elaborate on points. TikTok has kind of brainwashed me into just giving blurbs with zero explanation because the less you explain, the shorter the video, and the more comments you’ll get. I’ve gotten in the habit of giving less information” “I went on vacation and it was the first time in three years I was able to exist without that little voice in my head telling me you should be taking a photo right now, you should make a video about this, you should make a vlog, you should do a GRWM, you should post an update. It was liberating” “Usually my time is divided between me existing and then me posting about my existence. On this trip, I lived”

Jules

2,957,367 просмотров • 2 лет назад

Positioning of drugs in Crohn's disease ___ 1. Start effective therapy early This means at diagnosis in the vast majority of patients. Don’t make patients earn their way onto an effective drug. And use your best drug first. Please do not “save it in case you need it later”. ___ 2. Which of our effective therapies should you start? This matters less that just starting. Think holistically with a patient-centered approach. Age, co-morbidities, extra-intestinal manifestations, pregnancy, etc all important. Consider efficacy - speed of onset, mucosal healing, durability of remission - and safety. Mode of delivery - intravenous, subcutaneous, oral - is important. But comes after patient factors, efficacy and safety. Access issues will predominate for many. Use what you have. Use what you know. Just use an effective drug. ___ 3. Use a treat-to-target approach Without labouring the points around STRIDE-2, I’ll put it very simply: - monitor, monitor, monitor act on the results of the monitoring. Don’t keep going with a therapy that isn’t working. ___ 4. Know when to dose optimise versus switch Optimising anti-TNF is often a good ploy. But do it properly and don’t wait too long. Double the dose, shorten the frequency and wait 2-3 cycles. If it isn’t working then (objectively), switch out of class. With ustekinumab, I would no longer dose optimise, but rather switch a partial responder to risankizumab. ___ 5. Active disease is more dangerous than any drugs Two bits of data this year show this: i) In Profile, patients in the step-up group had twice as many adverse events as those in the top-down group. Most of this was because of flaring Crohn’s disease - including hospitalisations for severe disease - but there were also fewer serious infections in the top down group. And that was with combination infliximab and azathioprine. ii) Two meta-analyses of the harms from placebo in RCT’s show a very clear signal. Active Crohn’s disease and UC, when left untreated for even a number of week, is associated with increased toxicity. More on this later. ___ 6. Avoid steroids The majority of patients with Crohn’s disease can be managed effectively now without steroids. They will still have a role in sick patients, to bridge to some therapies, and a course of budesonide in mild to moderate ileal Crohn’s disease is often useful. However we have better strategies now, including using JAK inhibitors in place of steroids. We are increasingly using a short course to (re)capture response to a biologic or keeping the JAKi going in combination at a low dose. ___ 7. Other treatment modalities Surgery and nutritional therapy are particularly important. ___ 8. Changing the natural history of Crohn’s disease Disease modification is the end result when following these principles. We see it in the Edinburgh IBD clinic. A decade since we switched to a top-down strategy for Crohn’s disease and our patients have better disease control, less surgery and fewer hospitalisations. Clearly we still have work to do, but this is major progress.
4:55

Positioning of drugs in Crohn's disease ___ 1. Start effective therapy early This means at diagnosis in the vast majority of patients. Don’t make patients earn their way onto an effective drug. And use your best drug first. Please do not “save it in case you need it later”. ___ 2. Which of our effective therapies should you start? This matters less that just starting. Think holistically with a patient-centered approach. Age, co-morbidities, extra-intestinal manifestations, pregnancy, etc all important. Consider efficacy - speed of onset, mucosal healing, durability of remission - and safety. Mode of delivery - intravenous, subcutaneous, oral - is important. But comes after patient factors, efficacy and safety. Access issues will predominate for many. Use what you have. Use what you know. Just use an effective drug. ___ 3. Use a treat-to-target approach Without labouring the points around STRIDE-2, I’ll put it very simply: - monitor, monitor, monitor act on the results of the monitoring. Don’t keep going with a therapy that isn’t working. ___ 4. Know when to dose optimise versus switch Optimising anti-TNF is often a good ploy. But do it properly and don’t wait too long. Double the dose, shorten the frequency and wait 2-3 cycles. If it isn’t working then (objectively), switch out of class. With ustekinumab, I would no longer dose optimise, but rather switch a partial responder to risankizumab. ___ 5. Active disease is more dangerous than any drugs Two bits of data this year show this: i) In Profile, patients in the step-up group had twice as many adverse events as those in the top-down group. Most of this was because of flaring Crohn’s disease - including hospitalisations for severe disease - but there were also fewer serious infections in the top down group. And that was with combination infliximab and azathioprine. ii) Two meta-analyses of the harms from placebo in RCT’s show a very clear signal. Active Crohn’s disease and UC, when left untreated for even a number of week, is associated with increased toxicity. More on this later. ___ 6. Avoid steroids The majority of patients with Crohn’s disease can be managed effectively now without steroids. They will still have a role in sick patients, to bridge to some therapies, and a course of budesonide in mild to moderate ileal Crohn’s disease is often useful. However we have better strategies now, including using JAK inhibitors in place of steroids. We are increasingly using a short course to (re)capture response to a biologic or keeping the JAKi going in combination at a low dose. ___ 7. Other treatment modalities Surgery and nutritional therapy are particularly important. ___ 8. Changing the natural history of Crohn’s disease Disease modification is the end result when following these principles. We see it in the Edinburgh IBD clinic. A decade since we switched to a top-down strategy for Crohn’s disease and our patients have better disease control, less surgery and fewer hospitalisations. Clearly we still have work to do, but this is major progress.

Charlie Lees

15,650 просмотров • 1 год назад

🚨Aurora Police Fully Launch Real Time Information Center🚨 We’ve officially activated every piece of our Real Time Information Center (RTIC) and with this week’s launch of our Drones as First Responders program, the system is now fully live and working around the clock for Aurora. You’ve probably seen our posts, sharing how The RTIC has helped us track down criminals and solve crimes. The RTIC brings all our technology into one place: city cameras, Flock license plate readers, Drones as First Responders and the Axon FUSUS platform so our team can give officers real-time support the moment a call comes in.👏 The RTIC boosts both community and officer safety by using video technology to gather information and share that with officers on the ground as events unfold. Since going live in March, RTIC staff have helped officers➡️ • stay safer on dangerous calls • locate suspects faster • recover stolen vehicles • find missing children • gather real-time evidence to speed up investigations ‼️And the results speak for themselves‼️ • Arrests are up 48.7% compared to the same period last year. • Part 1 crime is down 24%, meaning 3,328 fewer victims in our community. “Adding the Flock Drones as First Responders program is the final piece bringing all the capabilities of our Real Time Information Center to fruition. This addition expands our real-time capabilities ensuring every response is as safe and effective as possible.” said Deputy Chief Phil Rathbun. The bottom line: The RTIC is helping us solve more crimes, reduce victimization and strengthen community and officer safety across Aurora. #APDInAction #CommunityCommitment [Media Description: Video sharing details and a showcase of APD's new Real Time Information Center.]
2:55

🚨Aurora Police Fully Launch Real Time Information Center🚨 We’ve officially activated every piece of our Real Time Information Center (RTIC) and with this week’s launch of our Drones as First Responders program, the system is now fully live and working around the clock for Aurora. You’ve probably seen our posts, sharing how The RTIC has helped us track down criminals and solve crimes. The RTIC brings all our technology into one place: city cameras, Flock license plate readers, Drones as First Responders and the Axon FUSUS platform so our team can give officers real-time support the moment a call comes in.👏 The RTIC boosts both community and officer safety by using video technology to gather information and share that with officers on the ground as events unfold. Since going live in March, RTIC staff have helped officers➡️ • stay safer on dangerous calls • locate suspects faster • recover stolen vehicles • find missing children • gather real-time evidence to speed up investigations ‼️And the results speak for themselves‼️ • Arrests are up 48.7% compared to the same period last year. • Part 1 crime is down 24%, meaning 3,328 fewer victims in our community. “Adding the Flock Drones as First Responders program is the final piece bringing all the capabilities of our Real Time Information Center to fruition. This addition expands our real-time capabilities ensuring every response is as safe and effective as possible.” said Deputy Chief Phil Rathbun. The bottom line: The RTIC is helping us solve more crimes, reduce victimization and strengthen community and officer safety across Aurora. #APDInAction #CommunityCommitment [Media Description: Video sharing details and a showcase of APD's new Real Time Information Center.]

Aurora Police Dept

56,028 просмотров • 10 месяцев назад

🚨BENEFITS OF DEDICATED BUS LANES🚨🇷🇼 🚍1. FASTER &RELIABLE TRAVEL •Buses avoid traffic congestion •Travel time becomes shorter and more predictable. •This improves schedule adherence and reduces passenger uncertainty. •Fewer delays, better punctuality. 📊 Example: •Before: Travel time varies between 20–45 minutes due to traffic •After: Travel time becomes 20–25 minutes consistently. 👉 Plan your journey with confidence ⏱️ 2. REDUCED WAITING TIME •Faster circulation allows buses to complete routes quicker. •Operators can provide more frequent service using the same fleet. •Less waiting at stops 📊 Example: •Before: One bus every 20 minutes → average waiting time ≈ 10 minutes •After: Faster trips allow one bus every 10 minutes → average waiting time ≈ 5 minute 👌Waiting time is cut by 50%, without adding more buses—just by improving speed and circulation. 👉 Save time every day. 🌍 3. ENVIRONMENTAL BENEFITS •Encourages people to shift from private cars to public transport. •Reduces traffic congestion, fuel consumption, and emissions. •Supports cleaner urban mobility and climate goals. 📊 Example: •Before: 1,000 people travel using 700 cars (average 1.4 persons/car) •After: 500 people shift to buses → only 350 cars remain. 👌350 fewer cars on the road → significant reduction in fuel use and emissions 👉 Move toward sustainable mobility 💰 4. COST EFFICIENCY •Higher speeds mean buses can serve more trips per day. •Better fleet utilization reduces the need for additional buses. •Lower operational costs per passenger. 📊 Example: •Before: One bus completes 4 trips/day •After: With faster lanes, same bus completes 6 trips/day •To serve 60 trips: Before → 15 buses needed After → 10 buses needed 👌 5 buses saved, reducing fuel, maintenance, and staffing costs 👉 Efficient & financially sustainable 💰 5. INCREASED PASSENGER CAPACITY •One dedicated bus lane can carry far more people than a car lane. •Moves large volumes efficiently, especially during peak hours. •Ideal for high-demand corridors. 📊 Example: •Car lane: 1,000 cars/hour × 1.5 persons ≈ 1,500 people/hour •Bus lane: 60 buses/hour × 50 passengers ≈ 3,000 people/hour 👌 Bus lane carries 2× more people using the same road space 👉 Move people, not just vehicles 🛣️ 6. IMPROVED ROAD SAFETY •Separate buses from traffic •Fewer conflicts & accidents •Safer for pedestrians & cyclists 📊 Example: •Before: 10 conflict points (cars + buses mixing at intersections and lanes) •After: Reduced to 4 conflict points with separated lanes 👉 Accidents drop, for example, from 20/year → 12/year (40% reduction) 🏙️ 7. SUSTAINABLE URBAN GROWTH •Supports compact city development:People live closer to transit •Reduces car dependency: More people choose buses •Better land use. 📊 Example: •Before: 70% of people rely on cars •After: Public transport share increases to 50% 👌 Less need for parking and wide roads → land can be used for housing, shops, and public spaces 👉 🏙️ Build smarter cities 📈 8. ECONOMIC PRODUCTIVITY •Less time in traffic •More time for work & life •Better access to jobs & services 📊 Example: •Before: 10,000 commuters lose 30 minutes/day in traffic Total lost time = 5,000 hours/day •After: Time lost reduced to 15 minutes/day Total lost time = 2,500 hours/day 👌 2,500 hours saved daily → more time for work and economic activity 👉 📈 Boost city efficiency ⚖️ 9. SOCIAL EQUITY •Provides faster, affordable mobility for all income groups. •Especially benefits those who rely on public transport daily. •Promotes inclusive urban development. 📊 Example: •Before: Low-income workers spend 90 minutes commuting •After: Travel time reduced to 60 minutes 👌 30 minutes saved daily, improving access to jobs and quality of life 👌 Affordable bus fares benefit 100% of users, not just car owners 👉 ⚖️ A system that works for everyone. 👏 Dedicated bus lanes: A simple solution with powerful impact.
3:32

🚨BENEFITS OF DEDICATED BUS LANES🚨🇷🇼 🚍1. FASTER &RELIABLE TRAVEL •Buses avoid traffic congestion •Travel time becomes shorter and more predictable. •This improves schedule adherence and reduces passenger uncertainty. •Fewer delays, better punctuality. 📊 Example: •Before: Travel time varies between 20–45 minutes due to traffic •After: Travel time becomes 20–25 minutes consistently. 👉 Plan your journey with confidence ⏱️ 2. REDUCED WAITING TIME •Faster circulation allows buses to complete routes quicker. •Operators can provide more frequent service using the same fleet. •Less waiting at stops 📊 Example: •Before: One bus every 20 minutes → average waiting time ≈ 10 minutes •After: Faster trips allow one bus every 10 minutes → average waiting time ≈ 5 minute 👌Waiting time is cut by 50%, without adding more buses—just by improving speed and circulation. 👉 Save time every day. 🌍 3. ENVIRONMENTAL BENEFITS •Encourages people to shift from private cars to public transport. •Reduces traffic congestion, fuel consumption, and emissions. •Supports cleaner urban mobility and climate goals. 📊 Example: •Before: 1,000 people travel using 700 cars (average 1.4 persons/car) •After: 500 people shift to buses → only 350 cars remain. 👌350 fewer cars on the road → significant reduction in fuel use and emissions 👉 Move toward sustainable mobility 💰 4. COST EFFICIENCY •Higher speeds mean buses can serve more trips per day. •Better fleet utilization reduces the need for additional buses. •Lower operational costs per passenger. 📊 Example: •Before: One bus completes 4 trips/day •After: With faster lanes, same bus completes 6 trips/day •To serve 60 trips: Before → 15 buses needed After → 10 buses needed 👌 5 buses saved, reducing fuel, maintenance, and staffing costs 👉 Efficient & financially sustainable 💰 5. INCREASED PASSENGER CAPACITY •One dedicated bus lane can carry far more people than a car lane. •Moves large volumes efficiently, especially during peak hours. •Ideal for high-demand corridors. 📊 Example: •Car lane: 1,000 cars/hour × 1.5 persons ≈ 1,500 people/hour •Bus lane: 60 buses/hour × 50 passengers ≈ 3,000 people/hour 👌 Bus lane carries 2× more people using the same road space 👉 Move people, not just vehicles 🛣️ 6. IMPROVED ROAD SAFETY •Separate buses from traffic •Fewer conflicts & accidents •Safer for pedestrians & cyclists 📊 Example: •Before: 10 conflict points (cars + buses mixing at intersections and lanes) •After: Reduced to 4 conflict points with separated lanes 👉 Accidents drop, for example, from 20/year → 12/year (40% reduction) 🏙️ 7. SUSTAINABLE URBAN GROWTH •Supports compact city development:People live closer to transit •Reduces car dependency: More people choose buses •Better land use. 📊 Example: •Before: 70% of people rely on cars •After: Public transport share increases to 50% 👌 Less need for parking and wide roads → land can be used for housing, shops, and public spaces 👉 🏙️ Build smarter cities 📈 8. ECONOMIC PRODUCTIVITY •Less time in traffic •More time for work & life •Better access to jobs & services 📊 Example: •Before: 10,000 commuters lose 30 minutes/day in traffic Total lost time = 5,000 hours/day •After: Time lost reduced to 15 minutes/day Total lost time = 2,500 hours/day 👌 2,500 hours saved daily → more time for work and economic activity 👉 📈 Boost city efficiency ⚖️ 9. SOCIAL EQUITY •Provides faster, affordable mobility for all income groups. •Especially benefits those who rely on public transport daily. •Promotes inclusive urban development. 📊 Example: •Before: Low-income workers spend 90 minutes commuting •After: Travel time reduced to 60 minutes 👌 30 minutes saved daily, improving access to jobs and quality of life 👌 Affordable bus fares benefit 100% of users, not just car owners 👉 ⚖️ A system that works for everyone. 👏 Dedicated bus lanes: A simple solution with powerful impact.

Dr. NDARUHUTSE Jean Claude, PhD

15,920 просмотров • 5 месяцев назад

Cody Hudson is a 2021 Florida C-19 vaccine-injured college student. His case is peer reviewed and published. After Rituxan/Rituximab treatment during his March hospitalization for two strokes and two blood clots in the heart, Cody experienced complete B-cell destruction to suppress the immune driver of his treatment-resistant blood clotting disorder antibodies. He still experiences strokes, DVT, pulmonary embolism, and microclotting even while fully anticoagulated. His T cells are now handling the heavy lifting for his immune system as we try to stabilize the disorder. Part of his story appears in this video describing the March 2026 hospitalization. We are working on a longer documentary that will cover what happened after that hospitalization on June 16, at home, when Cody experienced a massive flare of his insidious autoimmune blood clotting disorder, that suddenly brought on 30 to 40 pounds of localized lymphatic edema in both legs over three days! He then felt crushing chest pain, and we rushed him to the hospital. After a couple of hours at the hospital ER, he suffered a massive blood pressure drop and went into A-fib. During this ER visit- right in front of our eyes, he developed a large, severe microclotting wound over his left lower leg & foot that destroyed skin & tissue, creating a third-degree burn-like wound from below the knee down over the foot. To save his life, he required cardioversion twice—one chemical and one electrical. His heart ejection fraction was only 15%, and the situation was so severe that the hospital wanted to amputate his leg and move him to comfort care. His dad and I called our state surgeon general, who has followed Cody’s case closely. He and Senator Ron Johnson arranged a Medevac helicopter flight on Father’s Day to a level-one trauma center. We have been here with Cody for about a month. He was scheduled for skin grafting on the top of his foot after new skin failed to grow for 24 days, but surgery was delayed due to new bowel bleeding. He also developed myocarditis while on high-dose steroids. While awaiting surgery, his feet and lower legs began to show healing. I have been aggressively using silver gel products to treat the leg wound. At first I was reprimanded for not using hospital products, but then plastic surgery noted the new tissue growth. After seeing my comparison photos, they ordered silver sulfadiazine. Cody has been in this hospital about 30 days. About three weeks in, he developed pressure/bed sores and I used honey calcium alginate on the wounds, which closed completely within about eight hours. Quickly! Hospital “butt cream” and zinc products had not worked. I handle all Cody’s wound care, with the wound care team, dermatology, and ortho checking regularly. With his B cells destroyed by Rituxan, we must stay hyper-vigilant against infection. These large wounds can easily become infected, boggy, or necrotic. Infection is my biggest concern. Please continue praying with us that Cody avoids infection. His bowel is still bleeding, so the skin graft surgery is on hold, but we hope he can avoid it. Cody is tough as nails—in severe pain but fighting hard through this latest flare. He can’t fight this alone and we can’t fight this alone! We love you all for caring, checking in on Cody’s case, supporting our family, and helping his dad and me stay at his side. I feel desperately sorry for any family member stuck in the hospital who doesn’t get to stay with their loved one. I know that if Cody didn’t have us vigilantly watching over him and ensuring his legs receive the best possible products and care, he would have lost his leg by now. For him, amputation is a life-or-death situation, especially with a blood clotting disorder that does not respond to blood thinners. So we really, really need those prayers! To all those who follow his case, pray, support, send notes of encouragement, donate, and repost—we are so grateful for your prayers and support. 🫶🙏
2:30

Cody Hudson is a 2021 Florida C-19 vaccine-injured college student. His case is peer reviewed and published. After Rituxan/Rituximab treatment during his March hospitalization for two strokes and two blood clots in the heart, Cody experienced complete B-cell destruction to suppress the immune driver of his treatment-resistant blood clotting disorder antibodies. He still experiences strokes, DVT, pulmonary embolism, and microclotting even while fully anticoagulated. His T cells are now handling the heavy lifting for his immune system as we try to stabilize the disorder. Part of his story appears in this video describing the March 2026 hospitalization. We are working on a longer documentary that will cover what happened after that hospitalization on June 16, at home, when Cody experienced a massive flare of his insidious autoimmune blood clotting disorder, that suddenly brought on 30 to 40 pounds of localized lymphatic edema in both legs over three days! He then felt crushing chest pain, and we rushed him to the hospital. After a couple of hours at the hospital ER, he suffered a massive blood pressure drop and went into A-fib. During this ER visit- right in front of our eyes, he developed a large, severe microclotting wound over his left lower leg & foot that destroyed skin & tissue, creating a third-degree burn-like wound from below the knee down over the foot. To save his life, he required cardioversion twice—one chemical and one electrical. His heart ejection fraction was only 15%, and the situation was so severe that the hospital wanted to amputate his leg and move him to comfort care. His dad and I called our state surgeon general, who has followed Cody’s case closely. He and Senator Ron Johnson arranged a Medevac helicopter flight on Father’s Day to a level-one trauma center. We have been here with Cody for about a month. He was scheduled for skin grafting on the top of his foot after new skin failed to grow for 24 days, but surgery was delayed due to new bowel bleeding. He also developed myocarditis while on high-dose steroids. While awaiting surgery, his feet and lower legs began to show healing. I have been aggressively using silver gel products to treat the leg wound. At first I was reprimanded for not using hospital products, but then plastic surgery noted the new tissue growth. After seeing my comparison photos, they ordered silver sulfadiazine. Cody has been in this hospital about 30 days. About three weeks in, he developed pressure/bed sores and I used honey calcium alginate on the wounds, which closed completely within about eight hours. Quickly! Hospital “butt cream” and zinc products had not worked. I handle all Cody’s wound care, with the wound care team, dermatology, and ortho checking regularly. With his B cells destroyed by Rituxan, we must stay hyper-vigilant against infection. These large wounds can easily become infected, boggy, or necrotic. Infection is my biggest concern. Please continue praying with us that Cody avoids infection. His bowel is still bleeding, so the skin graft surgery is on hold, but we hope he can avoid it. Cody is tough as nails—in severe pain but fighting hard through this latest flare. He can’t fight this alone and we can’t fight this alone! We love you all for caring, checking in on Cody’s case, supporting our family, and helping his dad and me stay at his side. I feel desperately sorry for any family member stuck in the hospital who doesn’t get to stay with their loved one. I know that if Cody didn’t have us vigilantly watching over him and ensuring his legs receive the best possible products and care, he would have lost his leg by now. For him, amputation is a life-or-death situation, especially with a blood clotting disorder that does not respond to blood thinners. So we really, really need those prayers! To all those who follow his case, pray, support, send notes of encouragement, donate, and repost—we are so grateful for your prayers and support. 🫶🙏

Heather Hudson

22,468 просмотров • 2 месяцев назад

George Tolis: TAVR, Broken Training, and What's Really Wrong With Cardiac Surgery. Dr. George Tolis, section chief of coronary and general cardiac surgery at Brigham and Women's Hospital, joins Drs. Koka and DiGiorgio for a wide-ranging conversation on the state of cardiac surgery. He makes the case that TAVR — while genuinely transformative for the right patient — is being systematically applied too broadly, driven by industry incentive and the erosion of meaningful surgical consent. He discusses his collaboration with John Ioannidis that found no statistically significant mortality benefit for any new cardiac surgery technique introduced over the past 35 years, the paper's rejection by every major surgical journal, and what he paid out of pocket to make it open access. The conversation moves to the collapse of surgical training — fragmented pathways, work hour restrictions that leave residents unprepared for attending life, an academic promotion system that ignores teaching, and a culture that routes incompetent trainees around rather than out — and closes with a brief on Vasily Kolesov, the Soviet surgeon from Leningrad who performed the world's first documented coronary bypass years before Favaloro, and whose work was buried by the Cold War. Chapter Markers 00:00 Introduction 01:02 Air-cooled VWs, concert piano, and how Dr. Tolis got here 02:40 TAVR: genuine breakthrough or being abused? 08:02 Finding the TAVR threshold — and why informed consent is the real problem 11:46 Collaborating with John Ioannidis: no mortality benefit for 35 years of new techniques 20:02 Why the major surgical journals wouldn't touch the paper 21:52 Minimally invasive surgery: minimal access vs. minimally invasive 26:24 When do CABG survival curves diverge — and what does it mean? 30:05 Surgeons signing off on TAVRs in young patients 33:51 Health system economics and the heart team dynamic 37:50 How to actually pick a good surgeon (ask the scrub nurses) 40:36 Cardiac surgery training: the three pathways problem 44:04 Work hour restrictions and the residency simulation gap 51:16 General surgery is like MTV — they don't operate anymore 53:21 A resident who finished training without ever applying a cross-clamp 56:34 How to evaluate if a program actually trains 59:27 Academic promotion has nothing to do with teaching 01:01:33 Dr. Tolis's resident outcomes database and three papers nobody cared about 01:05:32 The training timeline: finishing at 49, no runway left 01:07:08 One-size-fits-all RRC rules for cardiac surgery and psychiatry 01:09:16 Cardiac surgery as a disposition, not a therapy 01:12:24 When ECMO becomes the final common path 01:13:38 How you become nationally recognized without being a good surgeon 01:17:16 Vasily Kolesov: the Soviet surgeon who did the first bypass Co-Host Handles Anish Koka, MD and Anthony DiGiorgio, DO, MHA Show Handle The Doctor’s Lounge Podcast Subscribe Links Spotify: Apple Podcasts: YouTube:
1:11:05

George Tolis: TAVR, Broken Training, and What's Really Wrong With Cardiac Surgery. Dr. George Tolis, section chief of coronary and general cardiac surgery at Brigham and Women's Hospital, joins Drs. Koka and DiGiorgio for a wide-ranging conversation on the state of cardiac surgery. He makes the case that TAVR — while genuinely transformative for the right patient — is being systematically applied too broadly, driven by industry incentive and the erosion of meaningful surgical consent. He discusses his collaboration with John Ioannidis that found no statistically significant mortality benefit for any new cardiac surgery technique introduced over the past 35 years, the paper's rejection by every major surgical journal, and what he paid out of pocket to make it open access. The conversation moves to the collapse of surgical training — fragmented pathways, work hour restrictions that leave residents unprepared for attending life, an academic promotion system that ignores teaching, and a culture that routes incompetent trainees around rather than out — and closes with a brief on Vasily Kolesov, the Soviet surgeon from Leningrad who performed the world's first documented coronary bypass years before Favaloro, and whose work was buried by the Cold War. Chapter Markers 00:00 Introduction 01:02 Air-cooled VWs, concert piano, and how Dr. Tolis got here 02:40 TAVR: genuine breakthrough or being abused? 08:02 Finding the TAVR threshold — and why informed consent is the real problem 11:46 Collaborating with John Ioannidis: no mortality benefit for 35 years of new techniques 20:02 Why the major surgical journals wouldn't touch the paper 21:52 Minimally invasive surgery: minimal access vs. minimally invasive 26:24 When do CABG survival curves diverge — and what does it mean? 30:05 Surgeons signing off on TAVRs in young patients 33:51 Health system economics and the heart team dynamic 37:50 How to actually pick a good surgeon (ask the scrub nurses) 40:36 Cardiac surgery training: the three pathways problem 44:04 Work hour restrictions and the residency simulation gap 51:16 General surgery is like MTV — they don't operate anymore 53:21 A resident who finished training without ever applying a cross-clamp 56:34 How to evaluate if a program actually trains 59:27 Academic promotion has nothing to do with teaching 01:01:33 Dr. Tolis's resident outcomes database and three papers nobody cared about 01:05:32 The training timeline: finishing at 49, no runway left 01:07:08 One-size-fits-all RRC rules for cardiac surgery and psychiatry 01:09:16 Cardiac surgery as a disposition, not a therapy 01:12:24 When ECMO becomes the final common path 01:13:38 How you become nationally recognized without being a good surgeon 01:17:16 Vasily Kolesov: the Soviet surgeon who did the first bypass Co-Host Handles Anish Koka, MD and Anthony DiGiorgio, DO, MHA Show Handle The Doctor’s Lounge Podcast Subscribe Links Spotify: Apple Podcasts: YouTube:

The Doctor’s Lounge Podcast

69,129 просмотров • 4 месяцев назад

🚨 Charlie Kirk: Operation 322 Intro + Disclaimer. CALL Candace Owens!! I've ACTUALLY linked Egypt to working with the Israel's IDF's Elbit Systems (with a local office right in Utah) via the UAE. 🤯 Think about that if you understand geopolitics... Really think about that. It is now UNDENIABLE that Elbit Systems "Bird of Prey" was the ONLY technology capable of this shot. This is my most researched and independently investigated 100% ORIGINAL find... I am proud of this discovery and contribution. All I ask is that y'all stop stealing my work, and using my research as your own dammit! 🤔😆 Credit me. Acknowledge me. I've worked too hard, and as an Army veteran I'm super sensitive to stolen valor type of mentalities... 🙌🏾 Not cool. 🙅🏾‍♂️ Anywho, I have assembled a list of undeniable shot factors that PROVE Charlie Kirk was shot TWICE on 9/10... Once you see my proof FRAME BY FRAME it is literally undeniable. My entire series is 5.5 the hours and I URGE you to read the comments section. The LOVE is AMAZING! 🫡 If you cannot do the entire series just watch Part IV. That is the final part of the series and has a very brief recap at the beginning... If you cannot sit through Part IV and need something shorter, check out the AI Review I put together. Either way there's something for everyone... And I'm doing another version right now as we speak... For the first time I'm going to group all of the evidence together that I show in the full 5.5 hours into a detailed 10 minute video... 🤯 I'm going to show you the drone recreation, the infrared laser, the palm shooter, both bullets, and so much more... CHECK OUT THIS INTRO VIDEO & A BRIEF MESSAGE FROM ME... If you're rocking with me, check out my LinkTree for the info... 🫡 And to stay up to date with everything going on "Charlie Kirk", be sure to check out my bro Project Constitution too!! 🤝🏾 Stay Alert, Stay Alive... 🪖🇺🇸🙏🏾 ~Tai
1:30

🚨 Charlie Kirk: Operation 322 Intro + Disclaimer. CALL Candace Owens!! I've ACTUALLY linked Egypt to working with the Israel's IDF's Elbit Systems (with a local office right in Utah) via the UAE. 🤯 Think about that if you understand geopolitics... Really think about that. It is now UNDENIABLE that Elbit Systems "Bird of Prey" was the ONLY technology capable of this shot. This is my most researched and independently investigated 100% ORIGINAL find... I am proud of this discovery and contribution. All I ask is that y'all stop stealing my work, and using my research as your own dammit! 🤔😆 Credit me. Acknowledge me. I've worked too hard, and as an Army veteran I'm super sensitive to stolen valor type of mentalities... 🙌🏾 Not cool. 🙅🏾‍♂️ Anywho, I have assembled a list of undeniable shot factors that PROVE Charlie Kirk was shot TWICE on 9/10... Once you see my proof FRAME BY FRAME it is literally undeniable. My entire series is 5.5 the hours and I URGE you to read the comments section. The LOVE is AMAZING! 🫡 If you cannot do the entire series just watch Part IV. That is the final part of the series and has a very brief recap at the beginning... If you cannot sit through Part IV and need something shorter, check out the AI Review I put together. Either way there's something for everyone... And I'm doing another version right now as we speak... For the first time I'm going to group all of the evidence together that I show in the full 5.5 hours into a detailed 10 minute video... 🤯 I'm going to show you the drone recreation, the infrared laser, the palm shooter, both bullets, and so much more... CHECK OUT THIS INTRO VIDEO & A BRIEF MESSAGE FROM ME... If you're rocking with me, check out my LinkTree for the info... 🫡 And to stay up to date with everything going on "Charlie Kirk", be sure to check out my bro Project Constitution too!! 🤝🏾 Stay Alert, Stay Alive... 🪖🇺🇸🙏🏾 ~Tai

WeAreNotGoingToMars

69,022 просмотров • 9 месяцев назад

🚨 WHY IS CASTOR OIL + IVERMECTIN GETTING SO MUCH ATTENTION? A simple combination is showing up in a growing number of online discussions: Castor oil + Topical Ivermectin. Dr. William Makis has discussed this combination in connection with topical routines and conversations surrounding breast cancer, head and neck cancer, and skin cancer. The idea goes beyond just using Ivermectin as an anti-parasitic. The combination being discussed Castor oil is typically applied topically around areas such as: • Under the arms • Behind the ears • Along the jawline • Behind the knees The discussion centers on castor oil's ricinoleic acid content and claims around circulation and lymphatic drainage. Topical Ivermectin came into the conversation just because of its established efficacy against certain parasites and its dermatological use. 🤔 Why Ivermectin stands out Ivermectin isn't just an internet trend. 1% topical Ivermectin is an FDA-approved treatment for inflammatory rosacea, with clinical trials showing improvement compared with vehicle cream. At the same time, researchers have been investigating Ivermectin's potential for drug repurposing in cancer. Laboratory and animal studies have reported anticancer activity across several cancer models, even though the human clinical evidence remains limited. That's where the Castor oil + Ivermectin conversation becomes particularly interesting. People are asking whether familiar, inexpensive compounds might have applications beyond their traditional uses. 📲 What people are reporting online Supporters of the routine have described experiences involving: • Less puffiness • Changes in skin appearance • Reduced feelings of swelling • Improved sleep • Changes in nerve discomfort • Changes in joint discomfort These are reported experiences, not established outcomes of the combination. But they're also part of the reason why the discussion keeps spreading. ✅ Castor oil ✅ Ivermectin ✅ Drug repurposing. Three familiar topics coming together in one increasingly discussed routine. 🔁 If you're following the growing Ivermectin conversation, save this post and share it with someone who has been researching topical Ivermectin. Looking for Ivermectin cream? Explore options through PharmacyinUSA, with worldwide delivery. #Ivermectin #CastorOil #WilliamMakis #IvermectinCream #CancerResearch #Rosacea #SkinHealth #PharmacyinUSA
0:46

🚨 WHY IS CASTOR OIL + IVERMECTIN GETTING SO MUCH ATTENTION? A simple combination is showing up in a growing number of online discussions: Castor oil + Topical Ivermectin. Dr. William Makis has discussed this combination in connection with topical routines and conversations surrounding breast cancer, head and neck cancer, and skin cancer. The idea goes beyond just using Ivermectin as an anti-parasitic. The combination being discussed Castor oil is typically applied topically around areas such as: • Under the arms • Behind the ears • Along the jawline • Behind the knees The discussion centers on castor oil's ricinoleic acid content and claims around circulation and lymphatic drainage. Topical Ivermectin came into the conversation just because of its established efficacy against certain parasites and its dermatological use. 🤔 Why Ivermectin stands out Ivermectin isn't just an internet trend. 1% topical Ivermectin is an FDA-approved treatment for inflammatory rosacea, with clinical trials showing improvement compared with vehicle cream. At the same time, researchers have been investigating Ivermectin's potential for drug repurposing in cancer. Laboratory and animal studies have reported anticancer activity across several cancer models, even though the human clinical evidence remains limited. That's where the Castor oil + Ivermectin conversation becomes particularly interesting. People are asking whether familiar, inexpensive compounds might have applications beyond their traditional uses. 📲 What people are reporting online Supporters of the routine have described experiences involving: • Less puffiness • Changes in skin appearance • Reduced feelings of swelling • Improved sleep • Changes in nerve discomfort • Changes in joint discomfort These are reported experiences, not established outcomes of the combination. But they're also part of the reason why the discussion keeps spreading. ✅ Castor oil ✅ Ivermectin ✅ Drug repurposing. Three familiar topics coming together in one increasingly discussed routine. 🔁 If you're following the growing Ivermectin conversation, save this post and share it with someone who has been researching topical Ivermectin. Looking for Ivermectin cream? Explore options through PharmacyinUSA, with worldwide delivery. #Ivermectin #CastorOil #WilliamMakis #IvermectinCream #CancerResearch #Rosacea #SkinHealth #PharmacyinUSA

PharmacyinUSA

110,778 просмотров • 1 день назад

I have a guest essay in The New York Times today about autonomous vehicle safety. I wrote it because I’m tired of seeing children die. Done right, we can eliminate car crashes as a leading cause of death in the United States Waymo recently released data covering nearly 100 million driverless miles. I spent weeks analyzing it because the results seemed too good to be true. 91% fewer serious-injury crashes. 92% less pedestrians hit. 96% fewer injury crashes at intersections. The list goes on. 39,000 Americans died in crashes last year. More than homicide, plane crashes, and natural disasters combined. The #2 killer of children and young adults. The #1 cause of spinal cord injury. We’ve accepted this as the price of mobility. We don’t have to. In medicine, when a treatment shows this level of benefit, we stop the trial early. Continuing to give patients the placebo becomes unethical. When an intervention works this clearly, you change what you do. In driving, we’re all the control group. Cities like DC and Boston are blocking deployment. And cities are not the only forces mobilizing to slow this progress. It’s time we stop treating this like a tech moonshot and start treating it like a public health intervention that will save lives. Link to article below. 👀 this video of Waymo cars evading crashes with people and vehicles. I especially note the ones that require it having a 360° view. My sincere thanks to Alex Ellerbeck and Alexandra Sifferlin for their wisdom and sure hand in editing this piece.
0:47

I have a guest essay in The New York Times today about autonomous vehicle safety. I wrote it because I’m tired of seeing children die. Done right, we can eliminate car crashes as a leading cause of death in the United States Waymo recently released data covering nearly 100 million driverless miles. I spent weeks analyzing it because the results seemed too good to be true. 91% fewer serious-injury crashes. 92% less pedestrians hit. 96% fewer injury crashes at intersections. The list goes on. 39,000 Americans died in crashes last year. More than homicide, plane crashes, and natural disasters combined. The #2 killer of children and young adults. The #1 cause of spinal cord injury. We’ve accepted this as the price of mobility. We don’t have to. In medicine, when a treatment shows this level of benefit, we stop the trial early. Continuing to give patients the placebo becomes unethical. When an intervention works this clearly, you change what you do. In driving, we’re all the control group. Cities like DC and Boston are blocking deployment. And cities are not the only forces mobilizing to slow this progress. It’s time we stop treating this like a tech moonshot and start treating it like a public health intervention that will save lives. Link to article below. 👀 this video of Waymo cars evading crashes with people and vehicles. I especially note the ones that require it having a 360° view. My sincere thanks to Alex Ellerbeck and Alexandra Sifferlin for their wisdom and sure hand in editing this piece.

Dr. Jon Slotkin

1,813,831 просмотров • 9 месяцев назад

Today, we’re announcing the first major discovery made by our AI Scientist with the lab in the loop: a promising new treatment for dry AMD, a major cause of blindness. Our agents generated the hypotheses, designed the experiments, analyzed the data, iterated, even made figures for the paper. The resulting manuscript is a first-of-a-kind in the natural sciences, in which everything that needed to be done to write the paper was done by AI agents, apart from actually conducting the physical experiments in the lab and writing the final manuscript. We are also introducing Robin, the first multi-agent system that fully automates the in-silico components of scientific discovery, which made this discovery. This is the first time that we are aware of that hypothesis generation, experimentation, and data analysis have been joined up in closed loop, and is the beginning of a massive acceleration in the pace of scientific discovery that will be driven by these agents. We will be open-sourcing the code and data next week. Robin is a multi-agent system that uses Crow, Falcon, and Finch, the agents on our platform, to generate novel hypotheses, plan experiments, and analyze data. We asked Robin to find a new treatment for dry age-related macular degeneration. Robin considered the disease mechanisms associated with dry AMD, proposed a specific experimental assay that could be used to evaluate hypotheses in the wet lab, and proposed specific molecules we could test in that assay. We tested the molecules and gave it the resulting data, which it analyzed before proposing more experiments. In the end, it identified Ripasudil, a Rho Kinase inhibitor (ROCK inhibitor) that is approved in Japan for several other diseases, which seems very promising as potential treatment for dry AMD. It also identified specific molecular mechanisms that might underlie the effects of Ripasudil in RPE cells, from an RNA sequencing experiment it proposed. To be clear, no one has proposed using ROCK inhibitors to treat dry AMD in the literature before, as far as we can find, and I think it would have been very difficult for us to come up with this hypothesis without the agents. We have also run the proposed treatment by several experts in AMD, who confirm that it is interesting and novel. Moreover, this project was fast: with Robin in hand, the entire project took about 10 weeks, which is way shorter than it would have taken if we had been doing all of the in-silico components ourselves. Important caveats: We are real biologists at FutureHouse, so I want to be clear that although the discovery here is exciting, we are not claiming that we have cured dry AMD. Fully validating this hypothesis as a treatment for dry AMD will take human trials, which will take much longer. Also, this discovery is cool, but it is not yet a "move 37"-style discovery. At the current rate of progress, I'm sure we will get to that level soon. Congratulations to the team. Congratulations in particular to Robin, which generated the hypotheses, proposed the experiments, analyzed the data and generated the figures. And major congratulations also to the human team, which built Robin: Michaela Hinks, Ali Ghareeb, Benjamin Chang, Ludovico Mitchener, Mo Razzak, Kiki Szostkiewicz, and Angela Yiu.
5:57

Today, we’re announcing the first major discovery made by our AI Scientist with the lab in the loop: a promising new treatment for dry AMD, a major cause of blindness. Our agents generated the hypotheses, designed the experiments, analyzed the data, iterated, even made figures for the paper. The resulting manuscript is a first-of-a-kind in the natural sciences, in which everything that needed to be done to write the paper was done by AI agents, apart from actually conducting the physical experiments in the lab and writing the final manuscript. We are also introducing Robin, the first multi-agent system that fully automates the in-silico components of scientific discovery, which made this discovery. This is the first time that we are aware of that hypothesis generation, experimentation, and data analysis have been joined up in closed loop, and is the beginning of a massive acceleration in the pace of scientific discovery that will be driven by these agents. We will be open-sourcing the code and data next week. Robin is a multi-agent system that uses Crow, Falcon, and Finch, the agents on our platform, to generate novel hypotheses, plan experiments, and analyze data. We asked Robin to find a new treatment for dry age-related macular degeneration. Robin considered the disease mechanisms associated with dry AMD, proposed a specific experimental assay that could be used to evaluate hypotheses in the wet lab, and proposed specific molecules we could test in that assay. We tested the molecules and gave it the resulting data, which it analyzed before proposing more experiments. In the end, it identified Ripasudil, a Rho Kinase inhibitor (ROCK inhibitor) that is approved in Japan for several other diseases, which seems very promising as potential treatment for dry AMD. It also identified specific molecular mechanisms that might underlie the effects of Ripasudil in RPE cells, from an RNA sequencing experiment it proposed. To be clear, no one has proposed using ROCK inhibitors to treat dry AMD in the literature before, as far as we can find, and I think it would have been very difficult for us to come up with this hypothesis without the agents. We have also run the proposed treatment by several experts in AMD, who confirm that it is interesting and novel. Moreover, this project was fast: with Robin in hand, the entire project took about 10 weeks, which is way shorter than it would have taken if we had been doing all of the in-silico components ourselves. Important caveats: We are real biologists at FutureHouse, so I want to be clear that although the discovery here is exciting, we are not claiming that we have cured dry AMD. Fully validating this hypothesis as a treatment for dry AMD will take human trials, which will take much longer. Also, this discovery is cool, but it is not yet a "move 37"-style discovery. At the current rate of progress, I'm sure we will get to that level soon. Congratulations to the team. Congratulations in particular to Robin, which generated the hypotheses, proposed the experiments, analyzed the data and generated the figures. And major congratulations also to the human team, which built Robin: Michaela Hinks, Ali Ghareeb, Benjamin Chang, Ludovico Mitchener, Mo Razzak, Kiki Szostkiewicz, and Angela Yiu.

Sam Rodriques

1,107,986 просмотров • 1 год назад

A revolutionary approach to defeating cancer: Dr. Patrick Soon-Shiong unveils a game-changing strategy In a riveting discussion, Dr. Patrick Soon-Shiong, a pioneering surgeon and biotech innovator, laid out a bold, chess-like strategy to outsmart cancer—an enemy he describes as diabolically clever, hiding from the body’s immune defenses with sinister precision. Forget checkers; this is a war requiring the sophistication of Go, where every move counts. Here’s how Dr. Soon-Shiong’s cutting-edge approach is rewriting the rules of cancer treatment: Step 1: Smoke Out the Enemy Cancer isn’t just a clump of cells—it’s a cunning adversary with genomic tricks that let it cloak itself from killer T-cells. Dr. Soon-Shiong’s protocol starts by exposing the cancer’s hidden receptors. Instead of blasting the tumor with high-dose chemotherapy, he uses a low metronomic dose—a tiny amount that stresses the cancer, forcing it to reveal itself. “It’s like smoking it out,” he explains. The cancer, sensing danger, exposes its surface molecules, making it a target for the immune system. Step 2: Unleash the Body’s Elite Forces With the tumor exposed, Dr. Soon-Shiong deploys the body’s natural killer (NK) cells and T-cells, supercharged by a breakthrough molecule called BioShield. This activates NK cells, stimulates killer T-cells, and—crucially—creates memory T-cells that remember the cancer’s signature. “For the first time, we’re seeing bladder cancer patients in complete remission for nine years, still alive, without losing their bladders,” he revealed. This isn’t just treatment; it’s a long-term defense system. Step 3: Orchestrate a Multi-Front Assault Cancer thrives by suppressing the immune system, but Dr. Soon-Shiong’s approach is a battlefield symphony. He educates T-cells with a tailored vaccine, activates killer macrophages, and suppresses the suppressors—all simultaneously. Radiation? Only in tiny, precise doses (SBRT) to expose, not destroy. “High-dose radiation kills your NK and T-cells,” he warns. This is precision warfare, not carpet bombing. A Future Without Suffering Unlike traditional cancer treatments that leave patients nauseous, bald, and broken, Dr. Soon-Shiong’s protocol is outpatient-based, minimizing suffering. “We’ve treated hundreds of patients this way,” he shared. Even more revolutionary? He envisions treating patients before surgery, using the tumor itself as a vaccine to train the immune system. Imagine a world where cancer is stopped in its tracks without invasive procedures. The American Red Cross of Cancer Dr. Soon-Shiong’s vision goes beyond individual patients. By extracting and cryopreserving NK and T-cells from a single pint of blood, his team can grow billions of these immune warriors, ready to be deployed for anyone. “We could become the American Red Cross of cancer,” he declared, hinting at a future where these innovations could even shape global health policy. Why This Matters Cancer isn’t just a disease; it’s a biological mastermind that demands respect and strategy. Dr. Soon-Shiong’s approach—expose, activate, educate, and suppress—offers hope to millions facing a life-threatening diagnosis. His work proves that with the right tools, we can turn the body into its own greatest weapon. The Call to Action The FDA must recognize this multi-pronged war requires battlefield awareness, not outdated single-drug approvals. Patients deserve access to these life-saving protocols now.
6:39

A revolutionary approach to defeating cancer: Dr. Patrick Soon-Shiong unveils a game-changing strategy In a riveting discussion, Dr. Patrick Soon-Shiong, a pioneering surgeon and biotech innovator, laid out a bold, chess-like strategy to outsmart cancer—an enemy he describes as diabolically clever, hiding from the body’s immune defenses with sinister precision. Forget checkers; this is a war requiring the sophistication of Go, where every move counts. Here’s how Dr. Soon-Shiong’s cutting-edge approach is rewriting the rules of cancer treatment: Step 1: Smoke Out the Enemy Cancer isn’t just a clump of cells—it’s a cunning adversary with genomic tricks that let it cloak itself from killer T-cells. Dr. Soon-Shiong’s protocol starts by exposing the cancer’s hidden receptors. Instead of blasting the tumor with high-dose chemotherapy, he uses a low metronomic dose—a tiny amount that stresses the cancer, forcing it to reveal itself. “It’s like smoking it out,” he explains. The cancer, sensing danger, exposes its surface molecules, making it a target for the immune system. Step 2: Unleash the Body’s Elite Forces With the tumor exposed, Dr. Soon-Shiong deploys the body’s natural killer (NK) cells and T-cells, supercharged by a breakthrough molecule called BioShield. This activates NK cells, stimulates killer T-cells, and—crucially—creates memory T-cells that remember the cancer’s signature. “For the first time, we’re seeing bladder cancer patients in complete remission for nine years, still alive, without losing their bladders,” he revealed. This isn’t just treatment; it’s a long-term defense system. Step 3: Orchestrate a Multi-Front Assault Cancer thrives by suppressing the immune system, but Dr. Soon-Shiong’s approach is a battlefield symphony. He educates T-cells with a tailored vaccine, activates killer macrophages, and suppresses the suppressors—all simultaneously. Radiation? Only in tiny, precise doses (SBRT) to expose, not destroy. “High-dose radiation kills your NK and T-cells,” he warns. This is precision warfare, not carpet bombing. A Future Without Suffering Unlike traditional cancer treatments that leave patients nauseous, bald, and broken, Dr. Soon-Shiong’s protocol is outpatient-based, minimizing suffering. “We’ve treated hundreds of patients this way,” he shared. Even more revolutionary? He envisions treating patients before surgery, using the tumor itself as a vaccine to train the immune system. Imagine a world where cancer is stopped in its tracks without invasive procedures. The American Red Cross of Cancer Dr. Soon-Shiong’s vision goes beyond individual patients. By extracting and cryopreserving NK and T-cells from a single pint of blood, his team can grow billions of these immune warriors, ready to be deployed for anyone. “We could become the American Red Cross of cancer,” he declared, hinting at a future where these innovations could even shape global health policy. Why This Matters Cancer isn’t just a disease; it’s a biological mastermind that demands respect and strategy. Dr. Soon-Shiong’s approach—expose, activate, educate, and suppress—offers hope to millions facing a life-threatening diagnosis. His work proves that with the right tools, we can turn the body into its own greatest weapon. The Call to Action The FDA must recognize this multi-pronged war requires battlefield awareness, not outdated single-drug approvals. Patients deserve access to these life-saving protocols now.

Camus

94,391 просмотров • 1 год назад

Johnson & Johnson Is The Largest, Costliest & Deadliest Criminal Conspiracy In American History. Grand Jury Documents Show They Caused & Contributed To The Deaths Of 2 Million People. Gardiner Harris, Investigative Journalist Their "No More Tears" Baby Loving Image Is A Lie. The deadly public health crises involves 9 different products produced & sold by Johnson & Johnson and its subsidiaries: Johnson’s Baby Powder, Tylenol, Procrit, Risperdal, Duragesic, Ortho Evra, the Pinnacle metal-on-metal hip implants, Prolift vaginal mesh & the Johnson & Johnson Covid-19 vaccine. Baby Powder: Johnson & Johnson knew that its talc powder was contaminated with asbestos, a highly carcinogenic mineral that causes cancers like mesothelioma. However, it hid this knowledge from the Food & Drug Administration (FDA) for decades. As a result, thousands of people, particularly women, got asbestos-related illnesses. Tylenol: Johnson & Johnson hid the evidence that Tylenol has a very narrow “margin of safety,” meaning that it is relatively easy to accidentally overdose on its active ingredient acetaminophen, which causes liver disease. Acetaminophen is the leading cause of Liver failure & the leading cause of Liver transplants in the US. Procrit: Johnson & Johnson hid studies that showed Procrit led to negative outcomes, particularly for cancer patients, as it led to the growth of cancerous tumors. Johnson & Johnson was also found liable for engaging in Medicare fraud in encouraging the prescription of this drug; it would provide Procrit to providers for low or no cost while asking the government for reimbursements for the full listed cost of the drug. Risperdal: An antipsychotic medication used in the treatment of bipolar disorder & schizophrenia that Johnson & Johnson claimed had fewer side effects than its older antipsychotic, Haldol. Johnson & Johnson illegally marketed the use of Risperdal to elderly patients with dementia & young patients with behavior disorders & depression. In elderly patients, Risperdal led to strokes, heart attacks & death. In younger patients, it led to metabolic disorders including diabetes & gynecomastia. Duragesic: A synthetic fentanyl patch used for the long-term treatment of severe pain. Johnson & Johnson marketed Duragesic as a less-addictive alternative to Purdue Pharma’s opioid OxyContin, despite evidence that fentanyl is just as addictive. Johnson & Johnson has an unacknowledged role in the ongoing opioid crisis in the United States. Ortho Evra: A hormonal contraceptive birth control patch. The patch delivers inconsistent levels of the hormone estrogen, leading to higher-than-average estrogen doses leading to blood clots & strokes. In some instances, the patch does not deliver enough estrogen, leading to pregnancy. Johnson & Johnson hid the unfavorable results of its Ortho Evra clinical trials from the FDA. Metal-on-Metal hip implants: Typically, hip implants are made from metal-on-plastic, as metal-on-metal wear & tear can lead to metal shards coming dislodged from the implant, embedding in muscle tissue & causing implant failure. The day before Johnson & Johnson sent its plans for a metal-on-metal implant to the FDA, an engineer reported one of its implants in a simulator had failed. Johnson & Johnson sent the original plans to the FDA for approval while changing the design without informing the regulatory agency. It hid reports of “adverse events,” or implant failure, from the agency. Prolift vaginal mesh: Inserted vaginally to help prevent the bladder from pressing against the vagina, causing incontinence & prolapse. Although the medical team that designed it raised concerns with the company about issues with the product, Johnson & Johnson put it on the market without asking for FDA approval. Over time, it became clear that the mesh would erode through thin vaginal walls causing terrible complications, including pain during sex. Many women had to have corrective surgery to remove the mesh. Johnson & Johnson Covid-19 vaccine: Although they had not developed vaccines, J & J wanted to do so in order to improve their public image following the backlash from the revelations about asbestos contamination in their baby powder. Johnson & Johnson created an adenovirus-based Covid-19 vaccine which did not need to be refrigerated & only one shot was required. Johnson & Johnson's vaccine proved to be harmful causing serious blood clots & Guillain-Barré syndrome. 👇No More Tears: The Dark Secrets Of J & J👇 👇Johnson & Johnson Litigation👇 👇Talc/Ovarian Cancer 60,000+ Lawsuits👇 Speaker: Gardiner Harris Video@ Dr. Josh Axe
1:32

Johnson & Johnson Is The Largest, Costliest & Deadliest Criminal Conspiracy In American History. Grand Jury Documents Show They Caused & Contributed To The Deaths Of 2 Million People. Gardiner Harris, Investigative Journalist Their "No More Tears" Baby Loving Image Is A Lie. The deadly public health crises involves 9 different products produced & sold by Johnson & Johnson and its subsidiaries: Johnson’s Baby Powder, Tylenol, Procrit, Risperdal, Duragesic, Ortho Evra, the Pinnacle metal-on-metal hip implants, Prolift vaginal mesh & the Johnson & Johnson Covid-19 vaccine. Baby Powder: Johnson & Johnson knew that its talc powder was contaminated with asbestos, a highly carcinogenic mineral that causes cancers like mesothelioma. However, it hid this knowledge from the Food & Drug Administration (FDA) for decades. As a result, thousands of people, particularly women, got asbestos-related illnesses. Tylenol: Johnson & Johnson hid the evidence that Tylenol has a very narrow “margin of safety,” meaning that it is relatively easy to accidentally overdose on its active ingredient acetaminophen, which causes liver disease. Acetaminophen is the leading cause of Liver failure & the leading cause of Liver transplants in the US. Procrit: Johnson & Johnson hid studies that showed Procrit led to negative outcomes, particularly for cancer patients, as it led to the growth of cancerous tumors. Johnson & Johnson was also found liable for engaging in Medicare fraud in encouraging the prescription of this drug; it would provide Procrit to providers for low or no cost while asking the government for reimbursements for the full listed cost of the drug. Risperdal: An antipsychotic medication used in the treatment of bipolar disorder & schizophrenia that Johnson & Johnson claimed had fewer side effects than its older antipsychotic, Haldol. Johnson & Johnson illegally marketed the use of Risperdal to elderly patients with dementia & young patients with behavior disorders & depression. In elderly patients, Risperdal led to strokes, heart attacks & death. In younger patients, it led to metabolic disorders including diabetes & gynecomastia. Duragesic: A synthetic fentanyl patch used for the long-term treatment of severe pain. Johnson & Johnson marketed Duragesic as a less-addictive alternative to Purdue Pharma’s opioid OxyContin, despite evidence that fentanyl is just as addictive. Johnson & Johnson has an unacknowledged role in the ongoing opioid crisis in the United States. Ortho Evra: A hormonal contraceptive birth control patch. The patch delivers inconsistent levels of the hormone estrogen, leading to higher-than-average estrogen doses leading to blood clots & strokes. In some instances, the patch does not deliver enough estrogen, leading to pregnancy. Johnson & Johnson hid the unfavorable results of its Ortho Evra clinical trials from the FDA. Metal-on-Metal hip implants: Typically, hip implants are made from metal-on-plastic, as metal-on-metal wear & tear can lead to metal shards coming dislodged from the implant, embedding in muscle tissue & causing implant failure. The day before Johnson & Johnson sent its plans for a metal-on-metal implant to the FDA, an engineer reported one of its implants in a simulator had failed. Johnson & Johnson sent the original plans to the FDA for approval while changing the design without informing the regulatory agency. It hid reports of “adverse events,” or implant failure, from the agency. Prolift vaginal mesh: Inserted vaginally to help prevent the bladder from pressing against the vagina, causing incontinence & prolapse. Although the medical team that designed it raised concerns with the company about issues with the product, Johnson & Johnson put it on the market without asking for FDA approval. Over time, it became clear that the mesh would erode through thin vaginal walls causing terrible complications, including pain during sex. Many women had to have corrective surgery to remove the mesh. Johnson & Johnson Covid-19 vaccine: Although they had not developed vaccines, J & J wanted to do so in order to improve their public image following the backlash from the revelations about asbestos contamination in their baby powder. Johnson & Johnson created an adenovirus-based Covid-19 vaccine which did not need to be refrigerated & only one shot was required. Johnson & Johnson's vaccine proved to be harmful causing serious blood clots & Guillain-Barré syndrome. 👇No More Tears: The Dark Secrets Of J & J👇 👇Johnson & Johnson Litigation👇 👇Talc/Ovarian Cancer 60,000+ Lawsuits👇 Speaker: Gardiner Harris Video@ Dr. Josh Axe

Valerie Anne Smith

71,636 просмотров • 1 год назад

Your baby doesn’t need screen time. 📱 📺 💻 You probably know that. But did you know that YOUR screen time also holds the potential to influence their development? In research from the University of Texas at Austin recently published in the journal Child Development, investigators synced recordings of mothers and their babies with mom’s smart phone usage records. What they found was that during periods of parental phone usage, verbal interactions between mothers and their babies dropped by 16%. (During comparatively shorter bursts of phone usage lasting less than 2 minutes, these interactions decreased even more - by 26%.) The bottom line: adult phone usage decreases one-on-one stimulation between infants and parents and exposes infants to less language. Screen time can be a touchy topic, I’ve found. And in today’s society it seems increasingly unrealistic to suggest that homes will be completely screen free - for parents or children. I’m a realist here. But perhaps the most interesting data point to come from this study is the average amount of parental smart phone usage they found among study participants: 4.4 HOURS per 12 hours studied. That’s a lot of screen time. The message here isn’t that parents need to (or realistically can) eliminate all smart phone usage. Many wouldn’t have that luxury even if they tried, due to work or other caregiving responsibilities. So what can be done? The authors suggest some important first steps: Being mindful of the impact phones can actually have on our our interactions/caregiving, and Remaining aware of how easily we can become consumed by our phones, despite our best intentions. After all, every minute we spend interacting with a screen is a minute that might otherwise be spent in the kind of brain-building, face-to-face interaction modeled so well by Campbell Williams in this lovely video she shared recently to TT (campbellwilliams_).
1:02

Your baby doesn’t need screen time. 📱 📺 💻 You probably know that. But did you know that YOUR screen time also holds the potential to influence their development? In research from the University of Texas at Austin recently published in the journal Child Development, investigators synced recordings of mothers and their babies with mom’s smart phone usage records. What they found was that during periods of parental phone usage, verbal interactions between mothers and their babies dropped by 16%. (During comparatively shorter bursts of phone usage lasting less than 2 minutes, these interactions decreased even more - by 26%.) The bottom line: adult phone usage decreases one-on-one stimulation between infants and parents and exposes infants to less language. Screen time can be a touchy topic, I’ve found. And in today’s society it seems increasingly unrealistic to suggest that homes will be completely screen free - for parents or children. I’m a realist here. But perhaps the most interesting data point to come from this study is the average amount of parental smart phone usage they found among study participants: 4.4 HOURS per 12 hours studied. That’s a lot of screen time. The message here isn’t that parents need to (or realistically can) eliminate all smart phone usage. Many wouldn’t have that luxury even if they tried, due to work or other caregiving responsibilities. So what can be done? The authors suggest some important first steps: Being mindful of the impact phones can actually have on our our interactions/caregiving, and Remaining aware of how easily we can become consumed by our phones, despite our best intentions. After all, every minute we spend interacting with a screen is a minute that might otherwise be spent in the kind of brain-building, face-to-face interaction modeled so well by Campbell Williams in this lovely video she shared recently to TT (campbellwilliams_).

Dan Wuori

89,813 просмотров • 1 год назад

Update: Young Cody Hudson (26- FL) will have the first of two skin graft surgeries to his extensively micro clot injured leg tomorrow. He is still hospitalized in critical condition for day 25 now, fighting for his life in advanced heart failure and at risk of leg amputation caused by blood clotting and micro-clotting as a result of his severe, vaccine-induced autoimmune clotting disorder that is well documented, peer reviewed and published and that he was left with since 2021. He was recently medivac transferred by helicopter to his current hospital in order to access a specialized, multidisciplinary care team equipped to handle his rare combination of heart failure, strokes, micro-clotting, and critical need for immune modulation to stop this aggressive autoimmune process. In June, he had a massive, inflammatory autoimmune event in which micro-clots in his blood have completely cut off circulation, acting like a severe third-degree burn all the way around his lower leg from the knee down. We had to request immediate helicopter transfer to his current hospital system on Father’s Day just a few weeks ago, to avoid leg amputation and to save his leg. I have been providing extensive wound care in the hospital for the past three weeks taking care of Cody’s leg- on my own and keeping it free of infection with the support of the staff here at the hospital. Tomorrow, he will have surgery to remove the dead tissue— this is the first of two skin graft surgeries on his left leg (or for both legs if they determine his right leg is severe enough)- A sobering aspect of these surgeries is that any surgery for a patient with Cody’s blood clotting condition is a terrifying tightrope between fatal blood clots and catastrophic bleeding with an extreme high risk compared to the general population. If the dead tissue is not removed- he could easily die of infection- we have been able to keep him free of infection in the legs, but the risk of death by infection is grater this surgery outweighs the risk of infection killing him. Because his case is so rare, I have dedicated years to researching these specific autoimmune injuries. My research is utilized globally in litigation and active state and federal government investigations. Cody’s medical team treats me as one of the experts on his team. I perform his specialized leg care daily and actively provide research in his case. He needs his mom and dad have to be at his bedside to help him. But we are at a breaking point. My husband is our sole provider, and he has missed three months to of work with zero pay to help me safely lift 6'3" Cody. This is the 5th year of Cody’s terminal illness and the extensive medical need have caused crushing financial hardship on our family. We desperately need to stay at Cody's side in the hospital to help save his life and protect him. We cannot do this alone anymore—we need your help. Please watch the short video below, this is the first time Cody has spoken publicly in some time. Please pray for Cody and the vaccine injured, donate to HELP Cody if you can, and REPOST to SHARE our fight to bring his important story to the public. Share on your FB and Instagram please and provide his GSG link. 🙏🌍👇 Give send go link:
0:26

Update: Young Cody Hudson (26- FL) will have the first of two skin graft surgeries to his extensively micro clot injured leg tomorrow. He is still hospitalized in critical condition for day 25 now, fighting for his life in advanced heart failure and at risk of leg amputation caused by blood clotting and micro-clotting as a result of his severe, vaccine-induced autoimmune clotting disorder that is well documented, peer reviewed and published and that he was left with since 2021. He was recently medivac transferred by helicopter to his current hospital in order to access a specialized, multidisciplinary care team equipped to handle his rare combination of heart failure, strokes, micro-clotting, and critical need for immune modulation to stop this aggressive autoimmune process. In June, he had a massive, inflammatory autoimmune event in which micro-clots in his blood have completely cut off circulation, acting like a severe third-degree burn all the way around his lower leg from the knee down. We had to request immediate helicopter transfer to his current hospital system on Father’s Day just a few weeks ago, to avoid leg amputation and to save his leg. I have been providing extensive wound care in the hospital for the past three weeks taking care of Cody’s leg- on my own and keeping it free of infection with the support of the staff here at the hospital. Tomorrow, he will have surgery to remove the dead tissue— this is the first of two skin graft surgeries on his left leg (or for both legs if they determine his right leg is severe enough)- A sobering aspect of these surgeries is that any surgery for a patient with Cody’s blood clotting condition is a terrifying tightrope between fatal blood clots and catastrophic bleeding with an extreme high risk compared to the general population. If the dead tissue is not removed- he could easily die of infection- we have been able to keep him free of infection in the legs, but the risk of death by infection is grater this surgery outweighs the risk of infection killing him. Because his case is so rare, I have dedicated years to researching these specific autoimmune injuries. My research is utilized globally in litigation and active state and federal government investigations. Cody’s medical team treats me as one of the experts on his team. I perform his specialized leg care daily and actively provide research in his case. He needs his mom and dad have to be at his bedside to help him. But we are at a breaking point. My husband is our sole provider, and he has missed three months to of work with zero pay to help me safely lift 6'3" Cody. This is the 5th year of Cody’s terminal illness and the extensive medical need have caused crushing financial hardship on our family. We desperately need to stay at Cody's side in the hospital to help save his life and protect him. We cannot do this alone anymore—we need your help. Please watch the short video below, this is the first time Cody has spoken publicly in some time. Please pray for Cody and the vaccine injured, donate to HELP Cody if you can, and REPOST to SHARE our fight to bring his important story to the public. Share on your FB and Instagram please and provide his GSG link. 🙏🌍👇 Give send go link:

Heather Hudson

47,386 просмотров • 2 месяцев назад